These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Attempting to Convert Primed Porcine Embryonic Stem Cells into a Naive State Through the Overexpression of Reprogramming Factors. Park TY; Choi KH; Lee DK; Oh JN; Kim SH; Lee CK Cell Reprogram; 2018 Oct; 20(5):289-300. PubMed ID: 30277824 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing. Wang LL; Zhao R; Li JY; Li SS; Liu M; Wang M; Zhang MZ; Dong WW; Jiang SK; Zhang M; Tian ZL; Liu CS; Guan DW Eur J Pharmacol; 2016 Sep; 786():128-136. PubMed ID: 27268717 [TBL] [Abstract][Full Text] [Related]
27. Reduced granulation tissue and wound strength in the absence of α11β1 integrin. Schulz JN; Zeltz C; Sørensen IW; Barczyk M; Carracedo S; Hallinger R; Niehoff A; Eckes B; Gullberg D J Invest Dermatol; 2015 May; 135(5):1435-1444. PubMed ID: 25634355 [TBL] [Abstract][Full Text] [Related]
28. Novel prospects for scarless wound healing: The roles of myofibroblasts and adipocytes. Teng YY; Zou ML; Zhou XJ; Wu JJ; Liu SY; Yuan ZD; Jia Y; Zhang KW; Li X; Ye JX; Yuan FL J Cell Mol Med; 2022 Oct; 26(20):5113-5121. PubMed ID: 36106529 [TBL] [Abstract][Full Text] [Related]
29. Cooperative Binding of Transcription Factors Orchestrates Reprogramming. Chronis C; Fiziev P; Papp B; Butz S; Bonora G; Sabri S; Ernst J; Plath K Cell; 2017 Jan; 168(3):442-459.e20. PubMed ID: 28111071 [TBL] [Abstract][Full Text] [Related]
30. Two Histone Variants TH2A and TH2B Enhance Human Induced Pluripotent Stem Cell Generation. Huynh LM; Shinagawa T; Ishii S Stem Cells Dev; 2016 Feb; 25(3):251-8. PubMed ID: 26649967 [TBL] [Abstract][Full Text] [Related]
31. Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate. Yamaguchi S; Hirano K; Nagata S; Tada T Stem Cell Res; 2011 Mar; 6(2):177-86. PubMed ID: 21130722 [TBL] [Abstract][Full Text] [Related]
32. Enhanced generation of human induced pluripotent stem cells by ectopic expression of Connexin 45. Ke Q; Li L; Yao X; Lai X; Cai B; Chen H; Chen R; Zhai Z; Huang L; Li K; Hu A; Mao FF; Xiang AP; Tao L; Li W Sci Rep; 2017 Mar; 7(1):458. PubMed ID: 28352086 [TBL] [Abstract][Full Text] [Related]
33. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing. Fang S; Xu C; Zhang Y; Xue C; Yang C; Bi H; Qian X; Wu M; Ji K; Zhao Y; Wang Y; Liu H; Xing X Stem Cells Transl Med; 2016 Oct; 5(10):1425-1439. PubMed ID: 27388239 [TBL] [Abstract][Full Text] [Related]
35. [Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling]. Liu W; Chua CH; Wu XL; Wang DR; Yin DM; Cui L; Cao YL; Longaker MT Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):31-6. PubMed ID: 12757642 [TBL] [Abstract][Full Text] [Related]
36. Transient reprogramming of postnatal cardiomyocytes to a dedifferentiated state. Kisby T; de Lázaro I; Stylianou M; Cossu G; Kostarelos K PLoS One; 2021; 16(5):e0251054. PubMed ID: 33951105 [TBL] [Abstract][Full Text] [Related]
37. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Ferguson MW; O'Kane S Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811 [TBL] [Abstract][Full Text] [Related]
38. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease. Kramann R; DiRocco DP; Humphreys BD J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178 [TBL] [Abstract][Full Text] [Related]
39. A decade of transcription factor-mediated reprogramming to pluripotency. Takahashi K; Yamanaka S Nat Rev Mol Cell Biol; 2016 Mar; 17(3):183-93. PubMed ID: 26883003 [TBL] [Abstract][Full Text] [Related]
40. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα. Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]